TENET HEALTHCARE CORP (THC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 2B 4B 6B Q3 '21: 4.9B Q4 '21: 4.9B Q1 '22: 4.7B Q2 '22: 4.6B Q3 '22: 4.8B Q4 '22: 5B Q1 '23: 5B Q2 '23: 5.1B Q3 '23: 5.1B Q4 '23: 5.4B Q1 '24: 5.4B Q2 '24: 5.1B Q3 '24: 5.1B Q4 '24: 5.1B Q1 '25: 0 Q2 '25: 0 Q3 '25: 5.3B Q4 '25: 5.5B Q1 '26: 413M Q2 '26: 413M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

0 1.5B 3B 4.5B Q3 '21: 1B Q4 '21: 751M Q1 '22: 648M Q2 '22: 553M Q3 '22: 596M Q4 '22: 536M Q1 '23: 603M Q2 '23: 604M Q3 '23: 568M Q4 '23: 735M Q1 '24: 3.3B Q2 '24: 761M Q3 '24: 1.1B Q4 '24: 821M Q1 '25: 943M Q2 '25: 823M Q3 '25: 889M Q4 '25: 853M Q1 '26: 1.3B Q2 '26: 1.5B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

0 800M 1.6B 2.4B Q3 '21: 578M Q4 '21: 419M Q1 '22: 280M Q2 '22: 179M Q3 '22: 268M Q4 '22: 274M Q1 '23: 296M Q2 '23: 293M Q3 '23: 266M Q4 '23: 456M Q1 '24: 2.3B Q2 '24: 477M Q3 '24: 681M Q4 '24: 572M Q1 '25: 622M Q2 '25: 522M Q3 '25: 579M Q4 '25: 644M Q1 '26: 906M Q2 '26: 1B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

0 600M 1.2B 1.8B Q2 '21: 245M Q3 '21: 432M Q4 '21: 357M Q1 '22: 228M Q2 '22: 119M Q3 '22: 315M Q4 '22: 421M Q1 '23: 449M Q2 '23: 598M Q3 '23: 503M Q4 '23: 824M Q1 '24: 586M Q2 '24: 747M Q3 '24: 1B Q1 '25: 815M Q2 '25: 936M Q3 '25: 1.1B Q4 '25: 731M Q1 '26: 1.6B Q2 '26: 585M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-500M 0 500M 1B 1.5B Q2 '21: 123M Q3 '21: 321M Q4 '21: 53M Q1 '22: 73M Q2 '22: -33M Q3 '22: 150M Q4 '22: 131M Q1 '23: 214M Q2 '23: 466M Q3 '23: 327M Q4 '23: 616M Q1 '24: 346M Q2 '24: 602M Q3 '24: 829M Q1 '25: 642M Q2 '25: 743M Q3 '25: 778M Q4 '25: 367M Q1 '26: 1.5B Q2 '26: 417M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q1 '20: 105.7M Q2 '20: 105.6M Q3 '20: 105.3M Q1 '21: 108.1M Q2 '21: 108.6M Q3 '21: 108.8M Q1 '22: 112M Q2 '22: 108.8M Q3 '22: 109.9M Q1 '23: 106M Q2 '23: 104.8M Q3 '23: 104.4M Q1 '24: 100.6M Q2 '24: 98.4M Q3 '24: 96.7M Q1 '25: 95M Q2 '25: 91.8M Q3 '25: 88.6M Q1 '26: 87.6M Q2 '26: 84M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-15.00 0.00 15.00 30.00 45.00 Q3 '20: -0.18 Q4 '20: 3.71 Q1 '21: 3.73 Q2 '21: 4.00 Q3 '21: 9.99 Q4 '21: 8.42 Q1 '22: 8.80 Q2 '23: 4.60 Q3 '23: 4.38 Q4 '23: 5.71 Q1 '24: 25.77 Q2 '24: 27.26 Q3 '24: 31.21 Q4 '24: 32.34 Q1 '25: 15.23 Q2 '25: 15.73 Q3 '25: 14.70 Q4 '25: 15.48 Q1 '26: 19.22 Q2 '26: 25.92 Q4 '20 Q3 '21 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.